Clinical study about adjuvant.

Clinical study about the intraocular operation using the adjuvant. - Clinical study about adjuvant.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs041180066

Enrollment

500

Registered

2019-03-07

Start date

2019-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract or retina vitreous disease and others.

Interventions

The adjuvant is triamcinolone,brilliant blue G,indocyanine green and fluorescein.We use the adjuvant with intraocular operation for improve the visibility of the desired lesion.We remove the adjuvant

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient who was enough explained and understand this study. The patient who agree this study by the free will and sign consent forms. The patient who was diagnosed adjuvant is appropriate.

Exclusion criteria

Exclusion criteria: The patient who judged adjuvant is inappropriate by principal investigator or member of a research project.

Design outcomes

Primary

Measure	Time frame
visual acuity	—

Secondary

Measure	Time frame
surgery time complication intraocular pressure electroretinogram study specular microscope study Laser flare cell meter study optical coherence tomography study	—

Contacts

Public ContactMasayuki Horiguchi

FUJITA HEALTH UNIVERSITY HOSPITAL

masayuki@fujita-hu.ac.jp+81-562-93-2000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026